Tokyo, Japan

Haruna Seo

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Haruna Seo: Innovator in Antisense Nucleic Acids

Introduction

Haruna Seo is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of antisense nucleic acids. With a total of five patents to her name, her work has the potential to impact therapeutic approaches for genetic disorders.

Latest Patents

Seo's latest patents focus on innovative methods for skipping specific exons in the human dystrophin gene. One of her notable inventions provides a drug that allows highly efficient skipping of exon 51 in the dystrophin gene. This antisense oligomer enables the targeted skipping of exon 51, which is crucial for developing treatments for conditions like Duchenne muscular dystrophy. Another patent presents a pharmaceutical agent that facilitates the skipping of exons 55, 45, 50, or 44 in the same gene with high efficiency. This invention also includes an oligomer designed to efficiently enable the skipping of these exons, showcasing her expertise in genetic therapies.

Career Highlights

Throughout her career, Haruna Seo has worked with esteemed organizations such as Nippon Shinyaku Company, Ltd. and the National Center of Neurology and Psychiatry. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Seo has collaborated with notable colleagues, including Shin'ichi Takeda and Tetsuya Nagata. These partnerships have further enhanced her research and development efforts in the realm of antisense technology.

Conclusion

Haruna Seo's innovative work in antisense nucleic acids positions her as a key figure in biotechnology. Her patents reflect her commitment to advancing medical science and improving treatment options for genetic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…